Clinical Trials Study
Copyright ©2014 Baishideng Publishing Group Inc.
World J Clin Cases. Oct 16, 2014; 2(10): 541-545
Published online Oct 16, 2014. doi: 10.12998/wjcc.v2.i10.541
Table 1 Demographic and disease variables according the group n (%)
VariableCategoryDS group (A)AA group (B)DS + AA group (C)P value1
GenderMale7(70.0)7(70.0)7(30.0)1.000
Female3(30.0)3(30.0)3(30.0)
Age, moAvarage ± SD (median)224.1 ± 86.0 (233.5)217.3 ± 90.2 (197.0)224.3 ± 86.9 (223.5)0.9702
Clinical presentation1 lesion S1(10.0)1(10.0)Descrip-tive
1 lesion S/cilium1(10.0)00.0
Lesions S6(60.0)9(90.0)
Lesion S/total1(10.0)00.0
Lesion S/total/eyebrow1(10.0)00.0
Family history of alopeciaYes002(20.0)000.230
No10(100.0)8(80.0)10(100.0)
Karyotypefree trisomy7(100.0)6(85.7)0.500
Translocation001(14.3)
Ethnic groupCaucasian6(60.0)3(30.0)7(70.0)0.270
Non-Caucasian4(40.0)7(70.0)3(30.0)
Family (n)0002(20.0)1(10.0)Descrip-tive
13(30.0)5(50.0)3(30.0)
22(20.0)1(10.0)00.0
32(20.0)1(10.0)00.0
400.01(10.0)2(20.0)
51(10.0)00.02(20.0)
61(10.0)00.01(10.0)
71(10.0)00.01(10.0)
Family (n)Avarage ± SD (median)3.1 ± 2.2 (2.5)1.4 ± 1.3 (1)3.4 ± 2.5 (4)0.0852
Table 2 Distribution of the most frequent human leukocyte antigen A, B, C, DQB1 and DRB1 alleles
AllelesDS group (A)AA group (B)DS + AA group (C)P value1
HLA-A 024(40.0)3(30.0)5(50.0)0.890
HLA-A 241(10.0)00.03(30.0)0.290
HLA-A 363(30.0)00.000.00.089
HLA-B 154(40.0)00.01(10.0)0.094
HLA-B 351(10.0)2(20.0)3(30.0)0.850
HLA-B 4400.02(20.0)4(40.0)0.120
HLA-B 533(30.0)1(10.0)1(10.0)0.570
HLA-C 024(40.0)00.02(20.0)0.120
HLA-C 074(40.0)3(30.0)5(50.0)0.890
HLA-C 151(10.0)3(30.0)00.00.290
HLA-DQB1 026(60.0)3(30.0)4(40.0)0.530
HLA-DQB1 032(20.0)6(60.0)5(50.0)0.270
HLA-DRB1 011(10.0)2(20.0)3(30.0)0.850
HLA-DRB1 034(40.0)3(30.0)2(20.0)0.880
HLA-DRB1 0400.01(10.0)2(20.0)0.750
HLA-DRB1 111(10.0)3(30.0)3(30.0)0.640
HLA-DRB1 133(30.0)2(20.0)4(40.0)0.880